A randomised, double-blind, dose-finding, phase II multicentre study of ODX in the treatment of patients with castration-resistant prostate cancer and skeletal metastases

Camilla Thellenberg-Karlsson, Egils Vjaters, Marju Kase, Teuvo Tammela, Kristiina Ojamaa, Ulf Norming, Claes Nyman, Sven Olof Andersson, Oleg Hublarovs, Marcela Marquez-Holmberg, Enrique Castellanos, Anders Ullen, Anders Holmberg, Sten Nilsson (Corresponding Author)

Research output: Contribution to journal › Article › peer-review

4 Citations (Scopus)
10 Downloads (Pure)

Fingerprint

Dive into the research topics of 'A randomised, double-blind, dose-finding, phase II multicentre study of ODX in the treatment of patients with castration-resistant prostate cancer and skeletal metastases'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science